醫院感染控制市場規模、佔有率和成長分析(按產品、應用、技術、疾病、最終用戶和地區分類)—產業預測(2026-2033 年)
市場調查報告書
商品編碼
1896915

醫院感染控制市場規模、佔有率和成長分析(按產品、應用、技術、疾病、最終用戶和地區分類)—產業預測(2026-2033 年)

Hospital-Acquired Infection Control Market Size, Share, and Growth Analysis, By Product, By Application, By Technology, By Disease, By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到 2024 年,醫院感染控制市場規模將達到 326.2 億美元,到 2025 年將達到 350 億美元,到 2033 年將達到 615 億美元,在預測期(2026-2033 年)內,複合年成長率為 7.3%。

醫院感染控制市場正經歷顯著成長,這主要得益於人們對預防交叉感染重要性的認知不斷提高,以及醫療機構感染疾病發生率居高不下。政府對感染控制舉措的支持也對市場動態起到了關鍵作用。各級醫療機構制定的嚴格感染預防標準和通訊協定,營造了以安全和衛生為中心的文化。此外,先進監測解決方案的日益普及也強化了這一趨勢,使醫療機構能夠實施積極主動的策略,有效預防和控制醫院感染。這些因素共同促成了醫院在維護病人安全和改善整體健康結果方面日益增強的投入。

醫院感染控制市場促進因素

全球醫院感染控制市場正經歷顯著成長,主要受每年手術量增加的推動。這一成長歸因於多種因素,包括肥胖症和其他需要手術治療的文明病發生率的上升。隨著手術量的增加,醫院感染的風險也隨之增加,凸顯了有效感染控制的迫切需求。因此,醫療機構正在增加對先進感染預防解決方案的投資,以提高病患安全並改善病患的整體治療效果。

限制醫院感染控制市場的因素

隨著醫療機構擴大選擇對可重複使用的醫療設備進行再處理以降低成本和減少廢棄物,醫院感染控制市場面臨挑戰。這種做法適用於多種器械,包括手術鉗、內視鏡和聽診器。儘管再處理具有經濟和環境效益,但人們仍對再處理器械的安全性和有效性感到擔憂。這些擔憂可能導致醫護人員和病患猶豫不決,進而影響醫療機構感染控制措施的整體實施。因此,人們對再處理相關風險的認知可能會限制市場成長和感染預防策略的創新。

醫院感染控制市場趨勢

醫院感染預防市場的一大趨勢是環氧乙烷滅菌技術的重新應用。該技術具有無與倫比的有效性,尤其適用於對溫度敏感的醫療器材。環氧乙烷滅菌技術的復興源於對能夠維持精密設備完整性的先進滅菌方法的需求不斷成長。然而,人們對環氧乙烷暴露相關健康風險的認知也顯著提高,這迫使醫療機構加強安全措施並採用新技術。隨著醫院在有效性和安全性之間尋求平衡,預計輸送系統和監測方法的創新將提升環氧乙烷在感染預防策略中的吸引力和接受度。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 一手和二手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2025)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析

全球醫院感染控制市場規模(按產品和複合年成長率分類)(2026-2033 年)

  • 保護屏障
  • 無菌
  • 消毒劑
    • 產品
    • 乾洗手劑
    • 表面消毒劑
    • 皮膚消毒劑
    • 器械消毒劑
    • 配方
    • 液體消毒劑
    • 消毒紙巾
    • 消毒噴霧
  • 消毒器
  • 內視鏡再處理產品
  • 其他

全球醫院感染控制市場規模(按應用及複合年成長率分類)(2026-2033 年)

  • 疾病檢測
  • 抗藥性檢測

全球醫院感染控制市場規模(依技術及複合年成長率分類)(2026-2033 年)

  • 表現型法
  • 基因分型方法

全球醫院感染控制市場規模:依疾病及複合年成長率分類(2026-2033 年)

  • 院內肺炎
  • 血液感染疾病
  • 手術部位感染
  • 胃腸道感染疾病
  • 尿道感染
  • 其他

全球醫院感染控制市場規模(按最終用戶和複合年成長率分類)(2026-2033 年)

  • 醫院/加護病房(ICU)
  • 門診手術及診斷中心
  • 安養院及婦產中心
  • 其他

全球醫院感染控制市場規模及複合年成長率(2026-2033)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • GCC
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

    主要企業簡介

    • 3M公司(美國)
    • 貝克頓·迪金森公司(BD)(美國)
    • 生物梅里埃公司(法國)
    • Ecolab Inc.(美國)
    • Getinge AB(瑞典)
    • 先進滅菌產品(ASP)(美國)
    • Belimed AG(瑞士)
    • 馬塔查納集團(西班牙)
    • MMM集團(德國)
    • 利潔時集團股份有限公司(英國)
    • Metrex Research LLC(美國)
    • 美諾集團(德國)
    • Pal International(英國)
    • Melag Medizintechnik GmbH & Co. KG(德國)
    • 康泰克公司(美國)
    • 梅達爾坎(希臘)
    • Systec GmbH(德國)
    • CBMSrl 醫療設備(義大利)
    • 美國大陸設備公司
    • BGS Beta-Gamma-Service GmbH & Co. KG(德國)

結論與建議

簡介目錄
Product Code: SQMIG35A2598

Hospital-Acquired Infection Control Market size was valued at USD 32.62 Billion in 2024 and is poised to grow from USD 35 Billion in 2025 to USD 61.5 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The Hospital Acquired Infection (HAI) control market is witnessing significant growth driven by increased awareness of the importance of preventing cross-infections and the high incidence of infectious diseases in healthcare settings. Government support for infection control initiatives also plays a crucial role in enhancing market dynamics. Strict infection prevention standards and protocols established across diverse healthcare levels foster a culture centered on safety and hygiene. Furthermore, the escalating use of advanced monitoring solutions strengthens this trend, enabling healthcare facilities to implement proactive strategies for effectively preventing and managing HAIs. These combined factors underscore a growing commitment to maintaining patient safety and improving overall health outcomes within hospitals.

Top-down and bottom-up approaches were used to estimate and validate the size of the Hospital-Acquired Infection Control market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Hospital-Acquired Infection Control Market Segments Analysis

Global Hospital-Acquired Infection Control Market is segmented by Product, Application, Technology, Disease, End User and region. Based on Product, the market is segmented into Protective Barrier, Sterilization, Disinfectants, Disinfectors, Endoscope Reprocessing Products and Other Infection Control Products. Based on Application, the market is segmented into Disease Testing and Drug-Resistance Testing. Based on Technology, the market is segmented into Phenotypic Methods and Genotypic Methods. Based on Disease, the market is segmented into Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection and Others. Based on End User, the market is segmented into Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers, Nursing Homes & Maternity Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Hospital-Acquired Infection Control Market

The global Hospital-Acquired Infection Control market has seen significant growth driven by the rising number of surgical procedures performed each year, which has reached an impressive volume globally. This surge can be attributed to various factors, including the increasing incidence of health conditions such as obesity and other lifestyle-related diseases, which often require surgical treatment. As more surgeries are conducted, the associated risk of hospital-acquired infections also escalates, highlighting the critical need for effective infection control measures. Consequently, healthcare facilities are increasingly investing in advanced infection prevention solutions to enhance patient safety and improve overall outcomes.

Restraints in the Hospital-Acquired Infection Control Market

The Hospital-Acquired Infection Control market faces a challenge as healthcare providers frequently choose to reprocess reusable medical devices to cut costs and minimize waste. This practice involves a diverse array of instruments, including surgical forceps, endoscopes, and stethoscopes. Despite the financial and environmental benefits, there are ongoing concerns about the safety and effectiveness of these reprocessed instruments. Such apprehensions can lead to hesitancy among healthcare professionals and patients alike, potentially impacting the overall adoption of infection control measures within medical facilities. As a result, the perceived risks associated with reprocessing may constrain market growth and innovation in infection prevention strategies.

Market Trends of the Hospital-Acquired Infection Control Market

The market for Hospital-Acquired Infection (HAI) control is witnessing a significant trend towards the reintroduction of ethylene oxide sterilization due to its unparalleled effectiveness, particularly for temperature-sensitive medical instruments. This resurgence is driven by an increasing demand for advanced sterilization methods that maintain the integrity of delicate devices. However, the evolving landscape is marked by a growing awareness surrounding the health risks tied to ethylene oxide exposure, prompting healthcare facilities to adopt improved safety protocols and technologies. As hospitals seek to balance efficacy with safety, innovations in delivery systems and monitoring practices are expected to enhance the appeal and acceptance of ethylene oxide in infection control strategies.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Hospital-Acquired Infection Control Market Size by Product & Services & CAGR (2026-2033)

  • Market Overview
  • Protective Barrier
  • Sterilization
  • Disinfectants
    • Product
    • Hand Disinfectants
    • Surface Disinfectants
    • Skin Disinfectants
    • Instrument Disinfectants
    • Formulation
    • Liquid Disinfectants
    • Disinfectant Wipes
    • Disinfectant Sprays
  • Disinfectors
  • Endoscope Reprocessing Products
  • Other Infection Control Products

Global Hospital-Acquired Infection Control Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Disease Testing
  • Drug-Resistance Testing

Global Hospital-Acquired Infection Control Market Size by Technology & CAGR (2026-2033)

  • Market Overview
  • Phenotypic Methods
  • Genotypic Methods

Global Hospital-Acquired Infection Control Market Size by Disease & CAGR (2026-2033)

  • Market Overview
  • Hospital Acquired Pneumonia
  • Bloodstream Infections
  • Surgical Site Infections
  • Gastrointestinal Infections
  • Urinary Tract Infection
  • Others

Global Hospital-Acquired Infection Control Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals & ICUs
  • Ambulatory Surgical & Diagnostic Centers
  • Nursing Homes & Maternity Centers
  • Others

Global Hospital-Acquired Infection Control Market Size & CAGR (2026-2033)

  • North America (Product & Services, Application, Technology, Disease, End User)
    • US
    • Canada
  • Europe (Product & Services, Application, Technology, Disease, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product & Services, Application, Technology, Disease, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product & Services, Application, Technology, Disease, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product & Services, Application, Technology, Disease, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • 3M Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (BD) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ecolab Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advanced Sterilization Products (ASP) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Belimed AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Matachana Group (Spain)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MMM Group (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Reckitt Benckiser Group plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Metrex Research LLC (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Miele Group (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pal International (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Melag Medizintechnik GmbH & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Contec, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MEDALKAN (Greece)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Systec GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • C.B.M. S.r.l. Medical Equipment (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Continental Equipment Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGS Beta-Gamma-Service GmbH & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations